DK1246611T3 - Formuleringer af aktive bestanddele i form af en fast dispersion - Google Patents

Formuleringer af aktive bestanddele i form af en fast dispersion

Info

Publication number
DK1246611T3
DK1246611T3 DK01915129T DK01915129T DK1246611T3 DK 1246611 T3 DK1246611 T3 DK 1246611T3 DK 01915129 T DK01915129 T DK 01915129T DK 01915129 T DK01915129 T DK 01915129T DK 1246611 T3 DK1246611 T3 DK 1246611T3
Authority
DK
Denmark
Prior art keywords
solid dispersion
formulations
active ingredients
solid
carrier
Prior art date
Application number
DK01915129T
Other languages
English (en)
Inventor
Bernhard Lippold
Nora Anne Urbanetz
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7627157&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1246611(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of DK1246611T3 publication Critical patent/DK1246611T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK01915129T 2000-01-11 2001-01-10 Formuleringer af aktive bestanddele i form af en fast dispersion DK1246611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10000792A DE10000792A1 (de) 2000-01-11 2000-01-11 Formulierungen von Wirkstoffen in Form einer festen Dispersion
PCT/EP2001/000224 WO2001051025A2 (de) 2000-01-11 2001-01-10 Formulierungen von wirkstoffen in form einer festen dispersion

Publications (1)

Publication Number Publication Date
DK1246611T3 true DK1246611T3 (da) 2008-01-28

Family

ID=7627157

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01915129T DK1246611T3 (da) 2000-01-11 2001-01-10 Formuleringer af aktive bestanddele i form af en fast dispersion

Country Status (9)

Country Link
US (1) US8021688B2 (da)
EP (1) EP1246611B1 (da)
AT (1) ATE373470T1 (da)
AU (1) AU2001242328A1 (da)
CA (1) CA2396722C (da)
DE (2) DE10000792A1 (da)
DK (1) DK1246611T3 (da)
ES (1) ES2293982T3 (da)
WO (1) WO2001051025A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
PL1830817T3 (pl) * 2004-12-30 2013-06-28 Pf Medicament Stała trwała dyspersja pochodnej alkaloidu Vinca i sposób jej wytwarzania
FR2880274B1 (fr) * 2004-12-30 2007-04-13 Pierre Fabre Medicament Sa Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication
AU2012357848C1 (en) * 2011-12-21 2018-07-19 Bayer Pharma Aktiengesellschaft Preparations containing amorphous emodepside
CN103271902B (zh) * 2013-05-07 2015-11-11 西安交通大学 一种难溶性药物固体分散体及其制备方法
CN109481411B (zh) * 2017-09-13 2021-02-02 亚宝药业集团股份有限公司 一种尼莫地平的热熔挤出固体分散体及其片剂制备方法
CN114699373B (zh) * 2022-03-30 2023-03-17 山东新时代药业有限公司 一种甲氧氯普胺固体分散体及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4292104A (en) * 1979-09-13 1981-09-29 Corning Glass Works Decalcomania manufacture
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3839825A1 (de) * 1988-11-25 1990-06-13 Henning Berlin Gmbh Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
US5080471A (en) * 1990-04-06 1992-01-14 Eic Laboratories, Inc. Electrochromic material and electro-optical device using same
JP2696438B2 (ja) * 1991-04-22 1998-01-14 富士写真フイルム株式会社 熱現像感光材料
CA2124821C (en) * 1991-12-18 2003-10-07 Isaac Ghebre-Sellassie Novel solid pharmaceutical dispersions
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition
US5599583A (en) * 1994-05-27 1997-02-04 Micro Flo Company Encapsulation with water soluble polymer
KR100239799B1 (ko) * 1995-01-21 2000-02-01 손경식 경구투여용 사이클로스포린 에이 고체미셀분산체, 이의 제조 방법 및 고형제제
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US6391338B1 (en) * 1995-09-07 2002-05-21 Biovail Technologies Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions

Also Published As

Publication number Publication date
WO2001051025A3 (de) 2002-04-18
WO2001051025A2 (de) 2001-07-19
DE50113030D1 (de) 2007-10-31
US20030109639A1 (en) 2003-06-12
DE10000792A1 (de) 2001-07-19
AU2001242328A1 (en) 2001-07-24
ATE373470T1 (de) 2007-10-15
ES2293982T3 (es) 2008-04-01
EP1246611B1 (de) 2007-09-19
EP1246611A2 (de) 2002-10-09
CA2396722A1 (en) 2001-07-19
US8021688B2 (en) 2011-09-20
CA2396722C (en) 2008-08-19

Similar Documents

Publication Publication Date Title
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
CY1117164T1 (el) Φαρμακευτικες συνθεσεις περιλαμβανουσες κολλοειδες διοξειδιο πυριτιου
KR910015298A (ko) 오메프라졸 직장투여조성물
EA200100838A1 (ru) Конъюгаты гксф
BR0115813A (pt) Polìmeros em forma de pente modificados por silìcio à base de ácido acriloil dimetiltaurìnico
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
CY1106908T1 (el) Φαρμακευτικη τυποποιηση απο του στοματος που περιεχει ενα αδρομερες συμπολυμερες
BR0113608A (pt) Composição cosmética clara em emulsão antiperspirante e/ou desodorante
DE60204820D1 (de) Antistatische Polymerzusammensetzungen
DE69714253T2 (de) Stickstoffoxydabgebendes präparat zur reduzierung der toxizität von wirkstoffen
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
DK1246611T3 (da) Formuleringer af aktive bestanddele i form af en fast dispersion
DE69906084D1 (de) Ibuprofen enthaltende schnelllösliche zusammensetzungen mit analgetischer wirkung
CA2338684A1 (en) Injectable propofol formulations
MX9305535A (es) Composiciones y concentrados germicidas a base de yodo-detergente, acuosos y estables.
WO2002047657A3 (en) Composition containing heteropolymers and oil-soluble polymers
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
HUP0000818A2 (hu) Vizes készítmények és alkalmazásuk
DK0420408T3 (da) Tandbehandlingspræparater
HRP20020071B1 (en) Pharmaceutical composition and preparation thereof
DE60108509D1 (de) Härtbare zusammensetzungen,die polysäure(n) und polyol(e) enthalten
MY122823A (en) Elastomer free, high efficacy antiperspirant stick
RU2001100069A (ru) Антгельминтное средство
RS50711B (sr) Insekticidna kompozicija koja ima poboljšanu skladišnu stabilnost